Pulsed field ablation registry for atrial arrhythmias in Poland.
Official title: Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland
Run by Wroclaw Medical University · NCT07109141 · Data updated 2026-11-12
This project will collect information to see how well pulsed field ablation works and how safe it is for people in Poland having ablation for atrial fibrillation, atrial flutter, or atrial tachycardia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Wroclaw Medical University Academic / other |
| Locations | 1 site (Wroclaw, Lower Silesian Voivodeship) |
| Status | Recruiting |
| Started | August 1, 2024 |
| Main results expected | July 1, 2030 |
| Study ends | July 1, 2030 |
| Registry record updated | August 7, 2025 |
| Trial ID | NCT07109141 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults in Poland who are undergoing pulsed field ablation for atrial arrhythmias (including atrial fibrillation, atrial flutter, or atrial tachycardia) and can give informed consent.
✕Probably not a fit
Patients who are not treated with PFA (for example those receiving conventional thermal ablation), those with ventricular arrhythmias only, or those who do not consent are unlikely to benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Pulsed field ablation (PFA) is a relatively new, tissue‑selective catheter technique based on irreversible electroporation that has shown safety and efficacy for pulmonary vein isolation in paroxysmal atrial fibrillation. This multicenter, nationwide registry will gather standardized clinical and procedural data from patients undergoing PFA for atrial arrhythmias outside the pulmonary veins, such as atrial flutter and atrial tachycardia. The registry will consolidate outcomes on procedural success, complications, and operator techniques to characterize real‑world use across Polish centers. Data from the registry are intended to inform best practices and support the planning of future randomized trials.
Why it matters
Potential benefit: If successful, the registry could improve understanding of PFA safety and effectiveness for non‑pulmonary‑vein atrial arrhythmias and help refine techniques and patient selection.
How similar studies have gone: Previous clinical studies have shown PFA to be effective and safe for pulmonary vein isolation in paroxysmal AF, but systematic evidence for its use in other atrial arrhythmias is limited and largely anecdotal.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed consent obtained from the participant * Subject is undergoing ablation of an atrial arrhythmia using the PFA Exclusion Criteria: \-
Where it's running
-
Clinical Department of Cardio, Jan Mikulicz Radecki University Hospital in Wroclaw
Wroclaw, Lower Silesian Voivodeship, Poland Recruiting
Study contacts
- Study coordinator: Stanislaw Tubek, MD, PhD
- Email: stanislaw.tubek@umw.edu.pl
- Phone: +48 71 733 11 12
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Electroporation versus Radiofrequency Ablation Guided by 3D Imaging for Repeat Atrial Fibrillation
This trial tests whether pulsed field electroporation or standard radiofrequency ablation works better and safer for people having a repeat catheter ablation for recurrent atrial fibrillation.
-
Factors Linked to Slow Heart Rate After Pulsed Field Ablation for Atrial Fibrillation
This study looks for factors that might cause bradycardia during the hospital stay after AF ablation using pulsed field technology.
-
Pulsed Field Ablation Outcomes in Atrial Fibrillation: Randomized Comparison to Traditional Ablation
This study tests pulsed field ablation versus conventional radiofrequency ablation in adults with atrial fibrillation to see which method better preserves heart rhythm.
-
Early rhythm control treatment for subclinical atrial fibrillation
This study tests whether starting rhythm-control treatments early can reduce abnormal heart rhythm episodes in people whose subclinical atrial fibrillation was found by implantable heart devices.
-
ICE-guided cavotricuspid isthmus ablation with a circular pulsed-field catheter
This will see if a circular-shaped pulsed field ablation catheter, guided by intracardiac echocardiography, can safely and effectively achieve acute cavotricuspid isthmus ablation in adults with atrial fibrillation.
-
Concomitant Pulsed Field Ablation and Left Atrial Appendage Closure in AF Patients
In patients with atrial fibrillation who need both ablation and left atrial appendage closure, this study tests doing both procedures in a single intervention using FARAPULSE PFA and a WATCHMAN FLX device.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.